Coloplast A/S (CPH:COLO.B)
589.00
-12.80 (-2.13%)
Nov 14, 2025, 4:59 PM CET
Coloplast Market Cap
Coloplast has a market cap or net worth of 132.74 billion as of November 14, 2025. Its market cap has decreased by -34.50% in one year.
Market Cap
132.74B
Enterprise Value
154.43B
Revenue
27.87B
Ranking
n/a
PE Ratio
36.52
Stock Price
589.00
Market Cap Chart
Since November 17, 1997, Coloplast's market cap has increased from 5.88B to 132.74B, an increase of 2,157.50%. That is a compound annual growth rate of 11.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 132.74B | -25.01% |
| Dec 30, 2024 | 177.00B | 2.05% |
| Dec 29, 2023 | 173.44B | 0.54% |
| Dec 30, 2022 | 172.51B | -29.57% |
| Dec 30, 2021 | 244.93B | 23.89% |
| Dec 30, 2020 | 197.71B | 12.62% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.42T |
| Genmab | 120.95B |
| ALK-Abelló | 50.87B |
| Demant | 47.76B |
| H. Lundbeck | 43.20B |
| Zealand Pharma | 36.67B |
| Ambu A/S | 22.88B |
| GN Store Nord | 15.62B |